neuropsychiatry-2018-scientifictracks

11 / 14

Page 34
Notes:
conferenceseries.com
Volume 4 Clinical Neuropsychology: Open Access Neuropsychiatry 2018
August 27-28, 2018
August 27-28, 2018 Tokyo, Japan
8th Global Experts Meeting on
Advances in Neurology and Neuropsychiatry
Amani Hassan et al., ClinNeuropsychol 2018, Volume 3
DOI: 10.4172/2472-095X-C1-002
The STOMP in children and adolescents with learning disabilities in SouthWales, UK
Amani Hassan and Collins Ann
Cwm Taf Health Board, UK
Background: Stopping Over Medication of People (STOMP) with a learning disability, autism or both is a project in the UK.
It looks at people being given psychotropic medicine because their behavior is seen as challenging. People with a learning
disability, autism or both are more likely to be given these medicines than other people without. These medicines can be good
for some people with mental illness or challenging behavior, but have side effects such as weight gain and tiredness so the less
people need this medicine, the better.
Aim: Our service is a tertiary service specializing in Child and Adolescent Mental Health Service (CAMHS) Learning Disability
(LD) in South Wales. It started in 2012 and covers 3 Health Boards. This project assessed how suitable the STOMP guidelines
are for our patients. We also thought about how the STOMP guideline might need to change for children and adolescents.
Methods: We looked at hospital notes of all 117 patients with mild to severe learning disabilities. Their age, gender, diagnosis
and what medicine they were taking were written down. When patients were taking psychotropic medicine, and if we were
following all of the STOMP guidelines was also recorded. If we were not doing what STOMP suggested, notes were explored
to find a reason.
Results: Positive Findings: (1) Clear reasons for prescribing were found in (98.39%). (2) Psycho educating patients and their
families with regard to risk and benefits (95.08%). (3) Regular follow ups (96.77%). (4) Care plans considered if medication was
still required (66.13%). Negative Findings: (1) Low percentage with regard to assessing capacity and gaining formal consent
(11.29%). (2) The service was rated low at explaining that a medicine is ‘off-label’ (4.55%).
Conclusion: CAMHS focuses their work on the whole family. Consent is gained from discussion with the family as a whole.
This needs to be formalized, as STOMP recommends. Capacity assessments are only relevant for over 16 year olds. Moving
forward CAMHS LD specific STOMP guidelines should be developed.
Biography
Amani Hassan is a Consultant Child and Adolescent Learning Disability Psychiatrist covering three local health boards in South Wales since 2012. She is also the
Chair C&A Faculty for Royal College of Psychiatrists in Wales, an Honorary Academic Associate and Researcher at Cardiff University and the Training Program
Director for CAMHS, Wales Deanery. Her previous post was Consultant Child and Adolescent Psychiatrist during 2010-2012 with Cwm Taf University Health Board
and was an Honorary QNIC Lead Reviewer for The Royal College of Psychiatrists during 2010-2011. She has gained other postgraduate qualifications following her
MBBS in 1989. She has a Diploma in Psychological Medicine, Cardiff University, MSc in Medical Law (LLM), Cardiff University and MSc in Clinical Neuropsychiatry,
Birmingham University. She became a Fellow of The Royal College of Psychiatrists in 2017. Her interests are research, publication and teaching. She is a Member
of IASSID and CAIDPN.